Investigating secondary hyperhidrosisPAISLEY, A. N; BUCKLER, H. M.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7774, pp 667-668, issn 1759-2151, 2 p.Article

Which androgen replacement therapy for women?BUCKLER, H. M; ROBERTSON, W. R; WU, F. C. W et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 11, pp 3920-3924, issn 0021-972XArticle

Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturityBUCKLER, H. M; ROBERTSON, W. R; SUN, J. G et al.Clinical endocrinology (Oxford. Print). 1992, Vol 37, Num 6, pp 552-557, issn 0300-0664Article

Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-biphosphonateANDERSON, D. C; O'DRISCOLL, J. B; BUCKLER, H. M et al.British journal of radiology. 1988, Vol 61, Num 731, pp 996-1001, issn 0007-1285Article

Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon)BUCKLER, H. M; ROBERTSON, W. R; ANDERSON, A et al.Human reproduction (Oxford. Print). 1999, Vol 14, Num 12, pp 2969-2973, issn 0268-1161Article

Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndromeBUCKLER, H. M; PHILLIPS, S. E; CAMERON, I. T et al.The Journal of clinical endocrinology and metabolism. 1988, Vol 67, Num 2, pp 300-306, issn 0021-972XArticle

Exceptional virilisation due to ovarian tumour and reversal after resectionBUCKLER, H. M; MITCHELL, D. M; BECK, M. H et al.British medical journal (1857). 1987, Vol 294, Num 6570, pp 480-481, issn 0007-1447Article

Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndromeBUCKLER, H. M; CRITCHLEY, H. O; CANTRILL, J. A et al.Clinical endocrinology (Oxford. Print). 1993, Vol 38, Num 2, pp 209-217, issn 0300-0664Article

Purified FSH stimulates production of inhibin by the human ovaryBUCKLER, H. M; HEALY, D. L; BURGER, H. G et al.Journal of endocrinology. 1989, Vol 122, Num 1, pp 279-285, issn 0022-0795Article

Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administrationBUCKLER, H. M; MCLACHLAN, R. I; MACLACHLAN, V. B et al.The Journal of clinical endocrinology and metabolism. 1988, Vol 66, Num 4, pp 798-803, issn 0021-972XArticle

Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)MITCHELL, R; BUCKLER, H. M; MATSON, P et al.Human reproduction (Oxford. Print). 1996, Vol 11, Num 5, pp 962-967, issn 0268-1161Article

Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cyclesBUCKLER, H. M; EVANS, C. A; MAMTORA, H et al.The Journal of clinical endocrinology and metabolism. 1991, Vol 72, Num 1, pp 116-124, issn 0021-972X, 9 p.Article

GnRH agonist administration in polycystic ovary syndromeBUCKLER, H. M; PHILLIPS, S. E; KOVACS, G. T et al.Clinical endocrinology (Oxford. Print). 1989, Vol 31, Num 2, pp 151-165, issn 0300-0664Article

Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of boneCANTRILL, J. A; BUCKLER, H. M; ANDERSON, D. C et al.Annals of the rheumatic diseases. 1986, Vol 45, Num 12, pp 1012-1018, issn 0003-4967Article